FDA's July update lists 211 newly cleared AI-enabled medical devices, with radiology comprising the majority.
Key Details
- 1211 AI-enabled medical devices cleared by the FDA since September 2024.
- 2About 81% of these updated clearances are radiology software products.
- 3QIH (automated radiological image processing) leads with 58 new clearances.
- 4New de novo authorization for Clairity's Allix5 software which analyzes breast cancer risk from images.
- 5Eight image analyzer products for mammography, ultrasound, and radiographs were reclassified from class III to class II in 2024.
- 6FDA plans to tag devices using foundation models, including LLMs and multimodal AI.
Why It Matters
Radiology continues to be at the forefront of FDA-cleared AI innovation, highlighting the field's rapid adoption of advanced technologies. Monitoring regulatory trends, device reclassifications, and transparency measures is critical for radiology and imaging AI professionals.
Source
AuntMinnie
Related News
•Health Imaging
Can ChatGPT Help Monitor AI Drift in Radiology?
Researchers explore using ChatGPT to monitor AI model drift for radiology applications.
•AI in Healthcare
White House AI Action Plan and Emerging Trends in Healthcare Imaging AI
The White House AI Action Plan, evolving GenAI monetization models, and AI governance challenges shape current healthcare AI debates.
•Health Imaging
Prognosia Breast AI Earns FDA Breakthrough Designation for Cancer Risk Prediction
Prognosia Breast, an AI-driven mammography tool, receives FDA Breakthrough Device status for improved five-year breast cancer risk prediction.